Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Turtle Cameron Insider Profile
4 Followers
Turtle Cameron, CBO at Eidos Therapeutics, holds 12.57K shares in BridgeBio Pharma (Ticker: BBIO), holds 50.62K shares in Eidos Therapeutics (Ticker: EIDX).
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-40.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Turtle Cameron holds in companies
Most Profitable Insider Trade
The most profitable trade made by Turtle Cameron
Turtle Cameron's Trading History
Eidos Therapeutics
Nov 13, 2020
CBO
Uninformative Sell
―
$4.56M
BridgeBio Pharma
Nov 25, 2020
SVP, Portfolio Management and Corporate Developmen
Uninformative Sell
235.16K
$617.47K
List of latest transactions for each holding click on a transaction to see Turtle Cameron's performance on stock
You May Also Like
Turtle Cameron insider profile FAQ
What is the percentage of profitable transactions made by Turtle Cameron?
The percentage of profitable transactions made by Turtle Cameron is 17%.
What is the average return per transaction made by Turtle Cameron?
The average return per transaction made by Turtle Cameron is -40.30%.
What stocks does Turtle Cameron hold?
Turtle Cameron holds: EIDX, BBIO stocks.
What was Turtle Cameron’s latest transaction?
Turtle Cameron latest transaction was an Uninformative Sell of $235.16K.
What was Turtle Cameron's most profitable transaction?
Turtle Cameron’s most profitable transaction was an Informative Sell of EIDX stock on September 6, 2019. The return on the trade was 2.10%.
What is Turtle Cameron's role in Eidos Therapeutics?
Turtle Cameron's role in Eidos Therapeutics is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.